Loisance D
Service de Chirurgie Thoracique et Cardiovasculaire, Centre de Recherches Chirurgicales Henri Mondor, CNRS URA 1431, Créteil.
Bull Acad Natl Med. 1995 Mar;179(3):537-46; discussion 547.
Hemocompatible biomaterials, i.e. materials to be used in a biological environment, are of various origins (biological, synthetic). The great variety of physical and chemical characteristics has allowed design of various prosthesis and artificial organs. Use of biomaterials and artificial organs has made possible the development of substitutive therapies, a growing component of medical care. None of the biomaterials presently used is ideal. Everyone of them is responsible for a local and general reaction: foreign body reaction, coagulation, whole body inflammatory response. For years, these reactions have been poorly understood and development was of a very empirical nature. Progress in cellular and molecular biology permits today a better understanding of the mechanisms involved in these reactions. Use of biomaterials is facing to day a difficult problem; liability concerns threaten further developments and leads to market withdrawal of major basic materials.
血液相容性生物材料,即用于生物环境的材料,有多种来源(生物的、合成的)。其多种多样的物理和化学特性使得各种假体和人造器官得以设计出来。生物材料和人造器官的使用使替代疗法得以发展,而替代疗法在医疗保健中的占比日益增加。目前使用的生物材料都不理想。它们中的每一种都会引发局部和全身反应:异物反应、凝血、全身炎症反应。多年来,这些反应一直未被充分理解,其发展具有很强的经验性。如今,细胞和分子生物学的进展使人们能够更好地理解这些反应所涉及的机制。如今,生物材料的使用面临一个难题;责任问题威胁到进一步的发展,并导致主要基础材料退出市场。